Tag Archives: INFI

Zacks: Brokerages Expect Infinity Pharmaceuticals, Inc. (INFI) to Announce -$0.20 EPS

Brokerages expect that Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) will announce ($0.20) earnings per share for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Infinity Pharmaceuticals’ earnings, with estimates ranging from ($0.21) to ($0.19). Infinity Pharmaceuticals reported earnings of ($0.34) per share in the same quarter last year, which would suggest a positive year-over-year growth rate of 41.2%. The firm is expected to announce its next earnings results on Thursday, August 2nd.

According to Zacks, analysts expect that Infinity Pharmaceuticals will report full-year earnings of ($0.74) per share for the current financial year, with EPS estimates ranging from ($0.77) to ($0.71). For the next fiscal year, analysts forecast that the business will report earnings of ($0.69) per share, with EPS estimates ranging from ($0.88) to ($0.59). Zacks’ EPS calculations are a mean average based on a survey of sell-side analysts that follow Infinity Pharmaceuticals.

Get Infinity Pharmaceuticals alerts:

Infinity Pharmaceuticals (NASDAQ:INFI) last announced its quarterly earnings data on Tuesday, May 8th. The biotechnology company reported ($0.18) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.18).

Separately, Zacks Investment Research downgraded Infinity Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Wednesday.

In other news, major shareholder Value Fund L. P. Biotechnology purchased 1,510,000 shares of the company’s stock in a transaction dated Tuesday, April 10th. The shares were purchased at an average price of $1.97 per share, with a total value of $2,974,700.00. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. 11.45% of the stock is owned by corporate insiders.

Hedge funds and other institutional investors have recently modified their holdings of the company. JPMorgan Chase & Co. purchased a new position in shares of Infinity Pharmaceuticals during the 3rd quarter valued at $135,000. Alambic Investment Management L.P. purchased a new position in shares of Infinity Pharmaceuticals during the 4th quarter valued at $158,000. Wells Fargo & Company MN lifted its position in shares of Infinity Pharmaceuticals by 654.7% during the 4th quarter. Wells Fargo & Company MN now owns 105,136 shares of the biotechnology company’s stock valued at $213,000 after buying an additional 91,206 shares during the last quarter. Goldman Sachs Group Inc. lifted its position in shares of Infinity Pharmaceuticals by 102.1% during the 4th quarter. Goldman Sachs Group Inc. now owns 150,375 shares of the biotechnology company’s stock valued at $305,000 after buying an additional 75,980 shares during the last quarter. Finally, Clear Harbor Asset Management LLC purchased a new position in shares of Infinity Pharmaceuticals during the 4th quarter valued at $312,000. 47.35% of the stock is currently owned by hedge funds and other institutional investors.

Infinity Pharmaceuticals remained flat at $$1.99 during trading on Friday, Marketbeat reports. The company’s stock had a trading volume of 369,500 shares, compared to its average volume of 677,495. The company has a market cap of $116.63 million, a P/E ratio of -2.40 and a beta of 2.50. Infinity Pharmaceuticals has a 52-week low of $0.93 and a 52-week high of $3.75.

Infinity Pharmaceuticals Company Profile

Infinity Pharmaceuticals, Inc, a biopharmaceutical company, develops medicines for people with cancer in the United States. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma (PI3K-gamma), which is in Phase 1/1b clinical study.

Get a free copy of the Zacks research report on Infinity Pharmaceuticals (INFI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Infinity Pharmaceuticals (NASDAQ:INFI)

best stock news

Shares of Harley-Davidson (HOG) had tumbled 8% this morning on reports that it had reached a settlement with the Department of Justice over the sale of devices that allow its motorcycles to exceed pollution limits. They have, however, since made a bit of a comeback. The reason, says Wells Fargo analyst Timothy Conder: Harley Davidson is not Volkswagen. He explains:

Associated Press

The Department of Justice (DoJ) and Harley-Davidson announced a settlement relating primarily to sales of Harley-Davidson after-market parts (competition off-road only ”super-tuner”) that allegedly increased pollution from the company’s motorcycles. Under terms of the settlement, which only applies to the U.S., (1) Harley admits no liability in the compromise to the differing interpretation of EPA regulations, (2) will buyback and destroy all ”super-tuners” from U.S. dealers, (3) pay $12MM in civil penalties, (4) spend $3MM to mitigate air pollution. Harley will continue to sell a performance on-road tuner that is EPA compliant. In addition to the combined $15MM in penalties/mitigation, we estimate that the buy-back destruction costs will ~$1MM. We believe investors will look through this settlement as a ”one-time” event impacting cash by less than $20MM.

best stock news: Infinity Pharmaceuticals, Inc.(INFI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell 0.32 percent. Meanwhile, top losers in the sector included Antares Pharma Inc (NASDAQ: ATRS), down 38 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI) down 16 percent.

  • [By Lisa Levin]

    Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares dropped 70 percent to $1.32. Infinity announced plans to cut 21 percent of the workforce. The company also reported that DYNAMO Phase 2 monotherapy study evaluating the efficacy and safety of duvelisib met its primary endpoint.

  • [By Lisa Levin]

    In trading on Tuesday, healthcare shares fell by 0.98 percent. Meanwhile, top losers in the sector included Cleveland BioLabs, Inc. (NASDAQ: CBLI), down 25 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI), down 8 percent.

best stock news: Staffing 360 Solutions, Inc.(STAF)

Advisors’ Opinion:

  • [By Matthew Briar]

    If there was any lingering doubt about Staffing 360 Solutions Inc (NASDAQ:STAF), it was wiped away today. The IT staffing firm’s second quarter numbers verify the long-standing growth trend is still well intact. Better still, even as the top line rises, expense-cuts supported by all the synergies of its recent acquisitions have allowed the bottom line to improve by even more.

    Even before today’s official Q2 announcement we knew that last quarter’s revenue would roll in at $47.1 million and gross profits would end up at $8.1 million. Those figures were up 14% and 8.4%, respectively. What we didn’t know about STAF until today is that the net loss shrank from $3.4 million a year earlier to only $1.5 million now. EBITDA of $1.4 million was about the same as the EBITDA of $1.3 million generated in the second fiscal quarter of the prior year.

    The progress march continues for Staffing 360 Solutions.

  • [By James E. Brumley]

    It’s almost time for the annual Staffing 360 Solutions Inc (NASDAQ:STAF) shareholder pow-wow. That is to say, the company’s annual shareholder meeting is scheduled for January 26th of the coming year, in New York City. Though nothing too dramatic is on the voting docket, a handful of items will be decided on by STAF owners.

    Staffing 360 Solutions is a fast-growing staffing firm. Its focal point is IT staffing. This small company is smartly and cost-effectively acquiring its way into a size and scale by converting a fragmented and less-effective and less profitable group of similar staffing agencies into a cohesive, more profitable singular unit.

    It’s paying off too – the proof has been in the rising revenue tally over the course of the past couple of years… a rise that’s been outpaced by the broad improvement of EBITDA and income (which is the point of a scale-up).

    The specific numbers: . All told, Staffing 360 Solutions generated $47.8 million worth of revenue last quarter, turned $8.5 million of it into a gross profit, and turned $1.8 million of that into an EBITDA profit. Those were, respectively, improvements of 33%, 34%, and 184% compared to the same quarter a year earlier. Net income improved too. The net loss of $1.3 million was 27% smaller than the net loss of $1.7 million booked in Q1 of fiscal 2016. Profitability – real profitability – is within reach. STAF simply has to stay on the trajectory it’s on. A couple more acquisitions and a little more organic growth could do the trick.

    Late next month, shareholders will have a chance to voice their thoughts on where the company should be going… metaphorically and literally. One of the matter being put to a vote is a change of domicile, from Nevada to Delaware; Delaware generally offers a more business-friendly set of operating and tax rules. Another more important matter to be voted on at the meeting is the authorization of more STAF shares, which have been used in lie

  • [By Matthew Briar]

    How does the old saying go? Numbers don’t lie? If that’s the case (and it IS true – numbers don’t lie), then Staffing 360 Solutions Inc (NASDAQ:STAF) remains in the right spot at the right time, and STAF shareholders have much to look forward to.

    Staffing 360 Solutions is a young and enterprising IT staffing firm that, for the record, is getting real big, real fast, by smartly and cost-effectively acquiring its way into a size and scale by converting a fragmented and less-effective (and less profitable) group of information-technology similar staffing agencies into a cohesive, more profitable singular unit.

    And a recent batch of data confirms that the company is barking up the right tree, so to speak.

    The latest round of numbers that bolster the bullish case for STAF are supplied by industry-research group Staffing Industry Analysts. Per the groups monthly Pulse Survey, in January, demand for IT staffing grew 11% on a year-over-year basis, improving on the 5% growth rate this sliver of the temporary-staffing industry saw in January of 2016. That’s the second-best growth pace among several the SIA monitors. Only demand for allied health workers was stronger.

    Of course, the news comes as no real surprise to regular followers of Staffing 360 Solutions, who have seen the company grow into a powerhouse, producing $47.1 million in revenue as of the most recent quarter. That was up 14% on a year-over-year basis, and half of that growth was organic (the other half came from smart acquisitions). Shareholders have seen the company grow from essentially nothing three years ago to what will eventually be a company driving $300 million in annual revenue.

    It’s not as if Staffing Industry Analysts are the only group out there saying the IT staffing arena is a red-hot opportunity. Technology research outfit recently opined that by the end of 2017, two-thirds of the CEOs of Global 2000 companies will have digital transformation at the ce

  • [By James E. Brumley]

    We week ago, IT staffing agency Staffing 360 Solutions Inc (NASDAQ:STAF) announced some very impressive preliminary second quarter numbers. Revenue of $47 million was up 14% year-over-year, while gross profits of $8.1 million grew 8% compared to year-ago levels. In both cases, the growth extended a long-term trend.

    As impressive as the forward progress for STAF was, though, it still wasn’t the whole story, nor were they the official numbers for the quarter in question. Per this weekend’s press release, Staffing 360 Solutions will give us the official version of the rest of the story on Wednesday of this week — the 11th — in the morning, shortly before a conference call slated for 9:00 am that morning. That announcement will add net income, EBITDA and operational cash flow numbers to the information shared last week, and should extend growth trends on those measures as well.

    Staffing 360 Solutions is putting together bigger IT staffing firm at the ideal time. A recent report from technology research outfit IDC, determined that by the end of 2017, two-thirds of the CEOs of Global 2000 companies will have digital transformation at the center of their corporate strategies. How are they going to make that happen? Deloitte recently posted some research of its own that should shed some light on the idea. The giant accounting form observed that “In order to maintain the competitive pace of innovation, companies find themselves engaged in a global war for talent.”

    That’s a trend also observed by the Department of Labor, which in its 2014-2024 occupational outlook handbook noted: “Employment of computer and information technology occupations is projected to grow 12 percent from 2014 to 2024, faster than the average for all occupations. These occupations are expected to add about 488,500 new jobs, from about 3.9 million jobs to about 4.4 million jobs from 2014 to 2024, in part due to a greater emphasis on cloud computing, the collection and

  • [By Bryan Murphy]

    Staffing agencies like Robert Half International Inc. (NYSE:RHI) and ManpowerGroup Inc. (NYSE:MAN) may want to look over their shoulder. Though both are bigger and more established, their size and the waning need for physical, human workers in an increasingly-digital and roboticized world ultimately works against both organizations. That paradigm shift doesn’t matter much to a young, up-coming-staffing agency called Staffing 360 Solutions Inc (NASDAQ:STAF) though. Indeed, the trend of computer-based everything leaves Staffing 360 Solutions in the proverbial cat-bird’s seat. Its fiscal Q2 numbers verify the company is in the right place at the right time.

    Those numbers? Revenue of $47.1 million was up 14%, and gross profits of $8.1 million were higher by 8.4% on a year-over-year basis. Moreover, the net loss of $1.5 million was a marked improvement on the year-ago loss of $3.5 million, and the EBITDA of $1.4 million was about the same. Operating expenses fell from 22% of revenue a year earlier to only 17% last quarter, with more such progress on the way.

    Perhaps most important, Staffing 360 Solutions saw organic growth of 7%, meaning the top line bumped up by that much not because of acquisitions, but because it’s existing divisions expanded their client base and billings by 7%.

    And last quarter’s progress has been the norm for several quarters now.

    While STAF is proving outpacing the growth from bigger names like ManpowerGroup and Robert Half International, it can’t come as a complete surprise. Staffing 360 Solutions is focused on the IT sliver of the staffing industry, connecting companies with the technology-skilled programmers, cybersecurity specialists, and computer networking personnel modern organizations increasingly need.

    There are several data nuggets that point in the same direction, but perhaps none as telling as a recent conclusion from technology research outfit IDC speaks volumes. IDC believes that by the

  • [By Peter Graham]

    Small cap staffing stock Staffing 360 Solutions Inc (NASDAQ: STAF), which is in the midst of a global buy-and-build strategy through the acquisition of domestic and international staffing organizations with operations in the US and UK, pre-announced its unaudited financial results for the fiscal second quarter ended November 30, 2016. Expected revenue rose 14% to$47 million and expected gross profit rose 8% to $8.1 million while for the first six months of the fiscal year, expected revenuerose 23% to$95 million and expected gross profit rose 20% to $16.6 million.

best stock news: J & J Snack Foods Corp.(JJSF)

Advisors’ Opinion:

  • [By Monica Gerson]

    J & J Snack Foods Corp (NASDAQ: JJSF) is estimated to post its quarterly earnings at $0.78 per share on revenue of $231.58 million.

    Nabors Industries Ltd. (NYSE: NBR) is expected to post a quarterly loss at $0.33 per share on revenue of $630.85 million.

best stock news: Monotype Imaging Holdings Inc.(TYPE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Wednesday afternoon, the non-cyclical consumer goods & services shares surged 0.61 percent. Meanwhile, top gainers in the sector included Monotype Imaging Holdings Inc. (NASDAQ: TYPE), up 9 percent, and Semiconductor Manufacturing Int'l (ADR) (NYSE: SMI), up 6 percent.

  • [By Lisa Levin]

    Shares of Monotype Imaging Holdings Inc. (NASDAQ: TYPE) were down around 12 percent to $20.90 after the company posted downbeat quarterly earnings.

best stock news: Meredith Corporation(MDP)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Meredith Corp. (NYSE: MDP) was maintained as Hold but the price target was raised to $65 (versus a $62.75 close) at Benchmark.

    Norfolk Southern Co. (NYSE: NSC) was downgraded to Underperform from Sector Perform at RBC Capital Markets.

  • [By Douglas A. McIntyre]

    Meredith Corp. (NYSE: MDP), the publishing, database and television station owner, has been described in several media reports as the most likely buyer of Time Inc. (NYSE: TIME). However, there are reports that the talks have stalled over valuation, which many experts believe will need to be above $20 a share to get the approval of Time’s board.

  • [By Lisa Levin]

    Meredith Corporation (NYSE: MDP), a company that owns multiple TV stations, digital and mobile operations and other media platforms, agreed to acquire Time Inc (NYSE: TIME), the content company best known for operating People, Time, Fortune, and Sports Illustrated magazines.

Hot Low Price Stocks To Buy Right Now

In my very first MannKind article I offered for my SA readers, I made the following statement:

Wall Street gurus are always smarter than the retail investor that doesn’t do their homework.

I have mentioned several times that MannKind’s (NASDAQ:MNKD) management understands the reality and has done a remarkable job in keeping the company hooked up to a life support system that has allowed them to be one of the few (other than the short-sellers) to benefit from these four years of futility for the retail investors. In recent days, with the flurry of superfluous SEC filings and press releases this has only resulted in the stock falling to a near all-time low price. The time is neigh for this saga becoming history so we can close the books on this financial fiasco. It’s now clear who has done their homework on MannKind!

Hot Low Price Stocks To Buy Right Now: Potash Corporation of Saskatchewan Inc.(POT)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Agri-Input Companies — Seeds/ Fertilizers/Pesticides Manufacturers

    Monsanto Company (NYSE: MON): +68.82 percent since 2011. Syngenta AG (ADR) (NYSE: SYT): +56.26 percent since 2011. Mosaic Co (NYSE: MOS): -63.1 percent since 2011. Potash Corporation of Saskatchewan (USA) (NYSE: POT): -67.8 percent since 2011. CF Industries Holdings, Inc. (NYSE: CF): +5.04 percent since 2011. Agrium Inc. (USA) (NYSE: AGU): +1.10 percent since 2011.

    Agri-Finance Companies

  • [By Ben Levisohn]

    We also want to reiterate our bullish view on the agricultural commodities and the ag-related stocks (e.g., CF Industries Holdings (CF), Mosaic (MOS), Potash Corp. of Saskatchewan (POT), FMC (FMC), AGCO, Deere). Following sharp multi-year declines, trends continue to improve.

Hot Low Price Stocks To Buy Right Now: Progress Software Corporation(PRGS)

Advisors’ Opinion:

  • [By Monica Gerson]

     

    General Mills, Inc. (NYSE: GIS) is expected to report its quarterly earnings at $0.60 per share on revenue of $3.86 billion.
    Pier 1 Imports Inc (NYSE: PIR) is projected to post a quarterly loss at $0.05 per share on revenue of $420.05 million.
    Acuity Brands, Inc. (NYSE: AYI) is estimated to report its quarterly earnings at $2.03 per share on revenue of $847.79 million.
    Monsanto Company (NYSE: MON) is projected to report its quarterly earnings at $2.40 per share on revenue of $4.49 billion.
    Worthington Industries, Inc. (NYSE: WOR) is expected to report its quarterly earnings at $0.64 per share on revenue of $692.48 million.
    Progress Software Corporation (NASDAQ: PRGS) is projected to post its quarterly earnings at $0.29 per share on revenue of $94.64 million.
    UniFirst Corp (NYSE: UNF) is estimated to report its quarterly earnings at $1.34 per share on revenue of $366.28 million.
    Exfo Inc (NASDAQ: EXFO) is expected to post its quarterly earnings at $0.06 per share on revenue of $60.87 million.
    OMNOVA Solutions Inc. (NYSE: OMN) is projected to report its quarterly earnings at $0.14 per share on revenue of $205.40 million.
    8Point3 Energy Partners LP (NASDAQ: CAFD) is estimated to post a quarterly loss at $0.01 per share on revenue of $11.60 million.
    Park Electrochemical Corp. (NYSE: PKE) is expected to report its quarterly earnings at $0.22 per share on revenue of $35.30 million.
    Xplore Technologies Corp. (NASDAQ: XPLR) is projected to post its quarterly earnings at $0.01 per share on revenue of $24.00 million.
    Investors Real Estate Trust (NYSE: IRET) is expected to post its quarterly earnings at $0.14 per share on revenue of $56.87 million.
    Tel-Instrument Electronics Corp. (NYSE: TIK) is estimated to post earnings for the latest quarter.
    Aethlon Medical, Inc. (NASDAQ: AEMD) is expected to post a quarterly loss at $0.20 per share.
    Ossen Innovation Co Ltd (ADR) (NASDAQ: OSN) is projected to post ea

  • [By Monica Gerson]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects ConAgra Foods Inc (NYSE: CAG) to report its quarterly earnings at $0.52 per share on revenue of $2.89 billion. ConAgra shares rose 0.17 percent to $47.68 in after-hours trading.
    Analysts expect Darden Restaurants, Inc. (NYSE: DRI) to report its quarterly earnings at $1.08 per share on revenue of $1.81 billion. Darden Restaurants shares gained 0.44 percent to $66.25 in after-hours trading.
    Progress Software Corporation (NASDAQ: PRGS) reported better-than-expected results for its second quarter on Wednesday. Progress Software shares surged 6.19 percent to $26.75 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Monica Gerson]

    Progress Software Corporation (NASDAQ: PRGS) is projected to post its quarterly earnings at $0.29 per share on revenue of $93.15 million.

    Sorl Auto Parts, Inc. (NASDAQ: SORL) is expected to post its quarterly earnings at $0.20 per share on revenue of $55.35 million.

Hot Low Price Stocks To Buy Right Now: Infinity Pharmaceuticals, Inc.(INFI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell 0.32 percent. Meanwhile, top losers in the sector included Antares Pharma Inc (NASDAQ: ATRS), down 38 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI) down 16 percent.

  • [By Lisa Levin]

    In trading on Tuesday, healthcare shares fell by 0.98 percent. Meanwhile, top losers in the sector included Cleveland BioLabs, Inc. (NASDAQ: CBLI), down 25 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI), down 8 percent.

  • [By Lisa Levin]

    Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares dropped 70 percent to $1.32. Infinity announced plans to cut 21 percent of the workforce. The company also reported that DYNAMO Phase 2 monotherapy study evaluating the efficacy and safety of duvelisib met its primary endpoint.

us stock exchange

Ashton Kutcher, Sound Ventures (Photo by Kevin Winter/Getty Images )

Eight months after launching in New York and 6 weeks after launching Illinois, Lemonade, the insurance company powered by AI and behavioral economics, launched across California.

It’s pretty fitting for the insurance disruptor to count California, the tech capital of the world, as its third state to be licensed in. Backed by VCs such as Sequoia, GV, General Catalyst and Ashton Kutcher’s Sound Ventures, Lemonade was founded by two techies themselves: Daniel Schreiber, the former president of Powermat, and Shai Wininger, a co-founder of Fiverr. In fact, the two describe Lemonade as a “tech company doing insurance, not an insurance company doing an app.”

This is not a trivial distinction. Insuretech has been billed the hottest sector in tech, and swarms of startups have sprung up in this past year. From 2011 and until 2017, overall insuretech venture funding grew by 31% annually, according to Venture Scanner. Often, “insurtech” companies are digital brokers that provide a snazzy facade for traditional insurance incumbents.

us stock exchange: Infinity Pharmaceuticals, Inc.(INFI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell 0.32 percent. Meanwhile, top losers in the sector included Antares Pharma Inc (NASDAQ: ATRS), down 38 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI) down 16 percent.

  • [By Lisa Levin]

    In trading on Tuesday, healthcare shares fell by 0.98 percent. Meanwhile, top losers in the sector included Cleveland BioLabs, Inc. (NASDAQ: CBLI), down 25 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI), down 8 percent.

  • [By Lisa Levin]

    Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares dropped 70 percent to $1.32. Infinity announced plans to cut 21 percent of the workforce. The company also reported that DYNAMO Phase 2 monotherapy study evaluating the efficacy and safety of duvelisib met its primary endpoint.

us stock exchange: M.D.C. Holdings, Inc.(MDC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cyclical consumer goods & services sector was the top gainer in the US market on Tuesday. Top gainers in the sector included M.D.C. Holdings, Inc. (NYSE: MDC), Delta Apparel, Inc. (NYSE: DLA), and Commercial Vehicle Group, Inc. (NASDAQ: CVGI).

us stock exchange: Kalytera Therapeutics, Inc. (QUEZF)

Advisors’ Opinion:

  • [By Javier Hasse]

    Kalytera Therapeutics Inc (OTC: QUEZF) closed a C$13.4 million ($10.2 million) tranche of a private placement for the acquisition of Talent Biotechs Ltd.

us stock exchange: Karyopharm Therapeutics Inc.(KPTI)

Advisors’ Opinion:

  • [By Chris Lange]

    Karyopharm Therapeutics Inc. (NASDAQ: KPTI) was raised to a Buy rating from Hold, and the price target was increased to $12 from $9, at Jefferies. The firm said its call is based on its future revenue opportunity in multiple myeloma. Itsshares most recently closed at $10.62, with a consensus price target of $16.30 and a 52-week range of $4.83 to $19.41.

us stock exchange: Coca-Cola Bottling Co. Consolidated(COKE)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    Coca-Cola Bottling Co. (NYSE: COKE) had a revenue increase to $2.3 billion in its most recentfiscal year, from $1.7 billion in the previous one. It is moving into Ohio, Indiana, Kentucky, Illinois and West Virginia, which almost certainly will require capital. Its net sales rose 37% in the most recent quarter to $840 million. Management stated this was because of “Organic growth in the legacy territories as well as territory expansion through the acquisition of several new distribution territories from Coca-Cola led to the solid performance.” The current dividend is $1, or 0.66%.

us stock exchange: Vascular Biogenics Ltd.(VBLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Vascular Biogenics Ltd (NASDAQ: VBLT) were down 17 percent to $7.43. VBL Therapeutics reported pricing of 2.5 million share common stock offering for $18.75 million.

  • [By Lisa Levin]

    Shares of Vascular Biogenics Ltd (NASDAQ: VBLT) were down 20 percent to $7.22. VBL Therapeutics reported pricing of 2.5 million share common stock offering for $18.75 million.

Top 5 Heal Care Stocks To Buy For 2018

Is the news out of the Trump White House giving us all FOMO (fear of missing out, that is), and making it impossible for other stories to be in the spotlight? CNN media reporters Oliver Darcy and Frank Pallotta talked about that with Brian Stelter in the most recent Reliable Sources podcast.

The two discussed the major media storylines of the week, including the live broadcast of O.J. Simpson’s parole hearing on multiple networks.

Nielsen reported that a mere 13 million people tuned in across the country, a sharp decline from the 150 million viewers who in 1995 watched Simpson’s murder trial verdict being announced.

By comparison, James Comey’s Senate testimony on June 8 drew in nearly 20 million viewers across 10 networks. Something about the Comey hearing made it feel like a “season finale,” Pallotta told Stelter, an event that “had everyone glued to their screen for hours,” Darcy added.

In times when Washington is a source of intrigue and mystery, people are engrossed by the breaking news cycle more than they are by their favorite TV series or other forms of entertainment. Darcy asked: “Who has time to watch Netflix, when the best show is on cable news?”

Top 5 Heal Care Stocks To Buy For 2018: Infinity Pharmaceuticals, Inc.(INFI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell 0.32 percent. Meanwhile, top losers in the sector included Antares Pharma Inc (NASDAQ: ATRS), down 38 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI) down 16 percent.

  • [By Lisa Levin]

    In trading on Tuesday, healthcare shares fell by 0.98 percent. Meanwhile, top losers in the sector included Cleveland BioLabs, Inc. (NASDAQ: CBLI), down 25 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI), down 8 percent.

  • [By Lisa Levin]

    Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares dropped 70 percent to $1.32. Infinity announced plans to cut 21 percent of the workforce. The company also reported that DYNAMO Phase 2 monotherapy study evaluating the efficacy and safety of duvelisib met its primary endpoint.

Top 5 Heal Care Stocks To Buy For 2018: Super Micro Computer, Inc.(SMCI)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Friday, small cap Super Micro Computer (NASDAQ: SMCI) fell 7.52% after receivingnotification letter from Nasdaq stating that the Company is not in compliance with Nasdaq listing rule 5250(c)(1), which requires timely filing of reports with the SEC. Super Micro Computer isa global leader in high-performance, high-efficiency server technology and innovation, is a premier provider of end-to-end green computing solutions for Data Center, Cloud Computing, Enterprise IT, Hadoop/Big Data, HPC and Embedded Systems worldwide. Supermicro’s advanced Server Building Block Solutions庐 offer a vast array of components for building energy-efficient, application-optimized, computing solutions. Architecture innovations include Twin, TwinPro, FatTwin, Ultra Series, MicroCloud, MicroBlade, SuperBlade庐, Simply Double, Double-sided Storage庐, Battery Backup Power (BBP庐) modules and WIO/UIO. Products include servers, blades, GPU systems, workstations, motherboards, chassis, power supplies, storage, networking, server management software and SuperRack庐 cabinets/accessories delivering unrivaled performance and value.

Top 5 Heal Care Stocks To Buy For 2018: eLong, Inc.(LONG)

Advisors’ Opinion:

  • [By Monica Gerson]

    eLong, Inc. (ADR) (NASDAQ: LONG) is projected to post a quarterly loss at $0.60 per share on revenue of $38.31 million.

    Qunar Cayman Islands Ltd (NASDAQ: QUNR) is expected to post a quarterly loss at $8.89 per share on revenue of $1.11 billion.

Top 5 Heal Care Stocks To Buy For 2018: North American Energy Partners, Inc.(NOA)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, energy shares slipped by 1.36 percent. Meanwhile, top losers in the sector included Northern Oil & Gas, Inc. (NYSE: NOG), down 9 percent, and North American Energy Partners Inc.(USA) (NYSE: NOA), down 6 percent.

Top 5 Heal Care Stocks To Buy For 2018: BioCryst Pharmaceuticals Inc.(BCRX)

Advisors’ Opinion:

  • [By Monica Gerson]

    BioCryst Pharmaceuticals (NASDAQ: BCRX) shares gained 5.98% to $6.91 in the pre-market session after the company has been awarded contract by the National Institute of Allergy and Infectious Diseases to develop BCX4430 for the treatment of Marburg virus disease.

  • [By Lisa Levin] Gainers
    Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate.
    Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA.
    Puma Biotechnology Inc (NASDAQ: PBYI) rose 21.7 percent to $99.75 in pre-market trading as the company disclosed positive PB272 Phase 2 data from TBCRC 022 trial at ASCO17.
    Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares rose 20.7 percent to $3.21 in pre-market trading after the company reported that RedZone has acquired all the assets of Trendit including three technology patents.
    Forestar Group Inc. (NYSE: FOR) rose 13.1 percent to $16.05 in pre-market trading after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash.
    TG Therapeutics Inc (NASDAQ: TGTX) shares rose 12 percent to $15.50 in pre-market trading after the company said Phase 3 GENUINE trial met primary endpoint with TG-1101 + ibrutinib increasing overall response rate by >70 percent versuss ibrutinib alone.
    Gigamon Inc (NYSE: GIMO) gained 10.8 percent to $43.55. Reuters reported that Gigamon is exploring a potential sale.
    BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 8.7 percent to $6.00 in pre-market trading after the company announced Rapivab pediatric sNDA acceptance by the FDA.
    Array Biopharma Inc (NASDAQ: ARRY) rose 7.2 percent to $8.77 in pre-market trading after gaining 5.68 percent on Friday.
    Ehi Car Services Ltd (ADR) (NYSE: EHIC) shares rose 6.4 percent to $10.76 in pre-market trading. eHi Car Services posted Q1 earnings of $0.06 on sales of $89.43 million.
    Skyworks Solutions Inc (NASDAQ: SWKS) rose 5.9 percent to $114.79 in pre-market trading after gaining 0.69 percent on Friday.
    Sorl Auto
  • [By Sean Williams]

    Shares of BioCryst Pharmaceuticals (NASDAQ:BCRX), a biotech company that develops small-molecule drugs to block enzymes involved in disease proliferation, surged as much as 12% today after a report was issued that a highly pathogenic H5N1 bird flu was found in the northern part of Malaysia.